Premium
Factors differentiating panic disorder with and without comorbid symptoms of depression
Author(s) -
BarrioMartínez Sara,
CanoVindel Antonio,
MuñozNavarro Roger,
Moriana Juan Antonio,
RuízRodríguez Paloma,
Medrano Leonardo Adrián,
Ventura Ludovica,
GonzálezBlanch César
Publication year - 2021
Publication title -
psychology and psychotherapy: theory, research and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.102
H-Index - 62
eISSN - 2044-8341
pISSN - 1476-0835
DOI - 10.1111/papt.12327
Subject(s) - panic disorder , somatization , major depressive disorder , psychology , depression (economics) , clinical psychology , somatization disorder , panic , cognition , comorbidity , psychiatry , anxiety , economics , macroeconomics
The aim of this study was to examine the sociodemographic and clinical differences between people with a probable diagnosis of panic disorder (PD) and those with PD and a probable comorbid diagnosis major depressive disorder (PD + MDD). We also sought to explore the potential contribution of cognitive variables to help differentiate between PD and PD + MDD. This was a subgroup analysis of 331 patients with PD symptoms who were included in the PsicAP clinical trial. All participants completed scales to evaluate panic, depression, somatization, cognitive and performance variables. A univariate analysis showed significant differences ( p < .01) between the groups (PD vs PD + MDD) in clinical variables. Somatization was the best predictor of comorbid PD + MDD (β = .346; p < .01). Cognitive variables do not appear to play an essential role in predicting the presence of depressive symptoms in people with a screen positive for PD. These findings appear to support a transdiagnostic treatment approach for PD, which may be useful regardless of whether comorbid depression is present or not. Practitioner points Somatic symptoms were associated with a higher probability of be in the PD + MDD group. Cognitive variables do not play a relevant role in the differentiation of both groups. A transdiagnostic approach can be useful for the treatment of PD or PD + MDD group.